All relevant data are in OSF: [10.17605/OSF.IO/VJSWA](https://doi.org/10.17605/OSF.IO/VJSWA).

Introduction {#sec006}
============

The proportion of older population is estimated to almost double by the year 2050, and the consequent increasing burden of health of this population is a global concern. Moreover, 80% of this population, is expected to be from low and middle-income countries \[[@pone.0233486.ref001]\]. The percentage of the older population (60 years and over) in Sri Lanka, a middle-income country has grown dramatically since 1981 \[[@pone.0233486.ref002]\] and has grown faster than other South Asian countries. In 2012, 1% of the total older population was institutionalized in Sri Lanka \[[@pone.0233486.ref003]\]. Although caring for this vulnerable group is considered a family obligation by Sri Lankans, a large number of older adults have been institutionalized in the past few decades possibly due to increased youth migration, smaller family size unable to deliver care responsibilities, and the increasing female labor force \[[@pone.0233486.ref004]\].

Long-term aged care facilities in many countries provide personalized nursing care for residents \[[@pone.0233486.ref005], [@pone.0233486.ref006]\]. In Sri Lanka, however, most patients in these facilities receive medical care from nearby hospital clinics. Most of these facilities do not employ trained healthcare professionals but employ staff who have not received any formal training on safe use of medicines, and a significant proportion are unpaid voluntary workers. Under these circumstances, it is highly likely that prescribing, dispensing and medication administration errors may not be identified by the untrained caregivers.

A study done in the United States (US) found that older adults had the highest age-specific adverse drug event rate; 3.8 per 10,000 persons per year, compared to other age groups \[[@pone.0233486.ref007]\]. The prevalence is much higher among residents in long-term aged care facilities globally \[[@pone.0233486.ref008]--[@pone.0233486.ref011]\]. Many studies have also reported a high prevalence of medication errors in long-term aged care facilities compared to hospitals \[[@pone.0233486.ref005], [@pone.0233486.ref012]\]. Published literature pertaining to developed countries report that 16%--90% of residents in these facilities have one or more medication errors \[[@pone.0233486.ref005], [@pone.0233486.ref013]--[@pone.0233486.ref015]\]. As older people experience complex and multiple co-morbidities, they are prescribed numerous medications. Multiple medication use, together with age-related changes in pharmacokinetics and pharmacodynamics, increase vulnerability to adverse drug events \[[@pone.0233486.ref012], [@pone.0233486.ref016], [@pone.0233486.ref017]\]. This danger may be augmented by functional disabilities such as visual hearing and mental impairment often seen in older adults.

Although many studies have been conducted on safe use of medications in long-term aged care facilities in high-income countries \[[@pone.0233486.ref005], [@pone.0233486.ref013], [@pone.0233486.ref014], [@pone.0233486.ref018], [@pone.0233486.ref019]\], there is a dearth of such data from low and middle-income countries \[[@pone.0233486.ref020], [@pone.0233486.ref021]\], especially research that assesses the overall medication process that includes prescribing, dispensing and administration. Clearly, the availability of healthcare services, the quality of care delivery, and health literacy of older people, considerably differ between low and middle-income countries and it is inappropriate to correlate such data from high-and low/middle income countries. Therefore, the aim of this study was to bridge this important information gap on the prevalence of prescribing, dispensing, medication administration, and storage errors in elderly care homes in Sri Lanka.

Materials and method {#sec007}
====================

Study design {#sec008}
------------

This study was an observational, prospective, cross-sectional, multi-center study conducted in nine selected elderly care homes in the Colombo District of Sri Lanka.

Study population {#sec009}
----------------

Residents aged 60 years or above with one or more non-communicable chronic diseases (NCCDs) and residing in the selected elderly care home for over three months were recruited for the study. Residents clinically diagnosed with cognitive impairment, those unable to communicate due to functional barriers, and those without competent caregivers to assist, were excluded from the study as they may not have been able to comprehend questions asked by the researchers or provide reliable responses to a medication history interview.

Colombo District was selected for the study through convenience sampling, but it is the District with the highest population density in Sri Lanka. Elders who were 60 years and above, residing in elderly care homes in the Colombo District were eligible for study. According to the list obtained from the Department of Social Services, Sri Lanka, 34 elderly care homes were registered in Colombo District but only 14 were functioning ([Fig 1](#pone.0233486.g001){ref-type="fig"}) during the study period. Of these, only nine were selected (366 residents), as officials of the other five elderly care homes did not grant permission for researchers to approach the residents and thereby refused access. Only 100 out of 366 residents in the nine elderly care homes matched the inclusion criteria ([Table 1](#pone.0233486.t001){ref-type="table"}). Therefore, finally, only a convenient sample of 100 older people were selected for the study.

![Flowchart of elderly care homes included in the study.](pone.0233486.g001){#pone.0233486.g001}

10.1371/journal.pone.0233486.t001

###### Proportion of residents recruited from elderly care homes selected for study.
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  Elderly care home identifier (total number of residents)   Residents selected for study   
  ---------------------------------------------------------- ------------------------------ -----
  Elderly care home 01 (N = 85)                              29                             34%
  Elderly care home 02 (N = 68)                              11                             16%
  Elderly care home 03 (N = 15)                              2                              13%
  Elderly care home 04 (N = 15)                              5                              33%
  Elderly care home 05 (N = 16)                              6                              38%
  Elderly care home 06 (N = 50)                              20                             40%
  Elderly care home 07 (N = 56)                              6                              11%
  Elderly care home 08 (N = 49)                              16                             33%
  Elderly care home 09 (N = 12)                              5                              42%
  Total                                                      100                            100

Study instruments and study process {#sec010}
-----------------------------------

This study used mixed methods including an interviewer-administered structured questionnaire, review of prescriptions and dispensing labels, and direct observation of medication administration and medication storage practices. Definitions of prescribing errors \[[@pone.0233486.ref022]\], dispensing errors \[[@pone.0233486.ref023]\], medication administration errors \[[@pone.0233486.ref022]\] and storage errors \[[@pone.0233486.ref024]\] were developed by researchers based on published literature \[[@pone.0233486.ref005]\] and were used as a guide to identify and classify medication errors ([S1 Table](#pone.0233486.s001){ref-type="supplementary-material"}).

An in-house pre-tested and validated (content and face) interviewer-administered questionnaire was used to gather information on demographic factors, disease conditions, and medication use practices of residents ([S1 File](#pone.0233486.s003){ref-type="supplementary-material"}). The research pharmacists obtained a complete medication history from the resident or caregiver and this was followed by a clinical prescription review to identify prescribing errors \[[@pone.0233486.ref025]\]. The identified problems were recorded in a predefined format. The current and latest available editions (at the time of the study) of British National Formulary (BNF) (Version 71) \[[@pone.0233486.ref026]\], the Australian Medicines Handbook (AMH) \[[@pone.0233486.ref027]\] and Medscape Pharmacists \[[@pone.0233486.ref028]\] were used as references for detecting prescribing errors.

The research pharmacists reviewed medication dispensing labels against the respective prescriptions to assess the appropriateness of the labels \[[@pone.0233486.ref005]\] and to detect identifiable dispensing errors for each medication. The name, dosage form, strength, dose, frequency, duration, the total quantity of units dispensed, and special instructions were considered in assessing the completeness and appropriateness of medication labels ([S2 File](#pone.0233486.s004){ref-type="supplementary-material"}). The Australian Pharmaceutical Formulary and Handbook (APF) (Version 21) \[[@pone.0233486.ref029]\] was used as a reference to assess the appropriateness of medication dispensing. This is an accepted reference used to guide pharmacists on good dispensing practices and contains the relevant instructions for dispensing labels.

The research pharmacists observed two medication administration cycles per resident: one morning cycle and one evening or night cycle, each on a separate day to identify administration errors \[[@pone.0233486.ref005], [@pone.0233486.ref030]\]. The two research pharmacists observed if the right medication was administered in the right dose (strength x number of medication units), at the right time and by the correct route against the most recent prescription of the resident. Any administration discrepancies were recorded as an administration error ([S3 File](#pone.0233486.s005){ref-type="supplementary-material"}).

Storage practices were directly observed by the research pharmacist \[[@pone.0233486.ref031]\] using a pre-defined checklist ([S4 File](#pone.0233486.s006){ref-type="supplementary-material"}) based on product information leaflets of relevant medications and referring to the Australian Pharmaceutical Formulary and Handbook (APF 21) \[[@pone.0233486.ref029]\].

Data were collected during a period of three months (from 1^st^ December 2016 to 28^th^ February 2017). The questionnaires and checklists used in the study were developed and reviewed by two experienced academic pharmacists. The questionnaire and checklists were then content validated by two other academic pharmacists and were piloted for feasibility in 10 older adults who were not part of the study. Data cleaning and an external audit was undertaken by an independent investigator. All problems related to prescribing, dispensing, medication administration, and storage that were identified during the study were checked and endorsed by two academic pharmacists and 100% consensus was achieved by discussion and re-categorizing where necessary.

Data analysis {#sec011}
-------------

Data were analyzed using SPSS, Version 16. Descriptive statistics are shown as means and frequencies with standard deviations. Prescribing errors were retrospectively categorized using part of the National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) Index for Categorizing Medication Errors shown in [S2 Table](#pone.0233486.s002){ref-type="supplementary-material"} \[[@pone.0233486.ref032]\].

Ethical consideration {#sec012}
---------------------

Ethical approval was obtained from the Ethics Review Committee, Faculty of Medical Sciences, University of Sri Jayewardenepura, Sri Lanka (B. Pharm 01/2016). Permission was obtained from the Social Services Department in Sri Lanka which is the authorized regulatory body for the management of elderly care homes and from the manager/head of each elderly care home prior to the study. Written and verbal consent in the resident's own language was obtained from all the residents who participated in the study. The purpose of the trial, the voluntary nature of the consent and the ability for participants to withdraw the consent were clearly explained before obtaining consent.

Results {#sec013}
=======

The study included 100 residents in nine elderly care homes in the Colombo District. The mean age of residents was 70±10.5 years and the majority were women (72%) ([Table 2](#pone.0233486.t002){ref-type="table"}). The most prevalent NCCD was hypertension (30.7%) followed by diabetes mellitus (27.8%) ([Table 2](#pone.0233486.t002){ref-type="table"}).

10.1371/journal.pone.0233486.t002

###### Demographics of the study population.
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  Demographics                                        Outcome
  --------------------------------------------------- ------------
  **Age (in years), mean (SD)**                       70 (10.5)
  **Gender, % **                                      
  Men                                                 28
  Women                                               72
  **Highest Level of Education, % **                  
  No schooling                                        52
  Grade 1--5                                          20
  Grade 6--11                                         15
  Completed Ordinary Level Examination                7
  Completed Advanced Level Examination                6
  **Assistance in medication administration, %**      
  By self                                             34
  By caregiver                                        66
  **Diagnosis, %**                                    
  Hypertension                                        30.7
  Diabetes mellitus                                   27.8
  Dyslipidemia                                        12.7
  Mental health problems                              6.9
  Bronchial asthma                                    4.6
  Gastroesophageal reflux disease                     2.3
  Myocardial infarction                               2.3
  Others[^a^](#t002fn002){ref-type="table-fn"}        12.7
  **Number of medications per resident, Mean (SD)**   4.46 (2.3)

SD = Standard deviation

^a^ Heart failure, hyper/hypothyroidism, osteoarthritis, rheumatoid arthritis, epilepsy, cerebral atrophy, parkinsonism, glaucoma

A total of 99 residents had at least one medication error (prescribing, dispensing, administration or storage errors).

Prescribing errors {#sec014}
------------------

Among 446 medications reviewed, 168 prescribing errors were identified. The mean number of prescribing errors per resident was 1.68±1.23 \[median, 2.00 (1.00--3.00)\]. Eighty-five percent of residents had at least one prescribing error.

The most common types of prescribing errors were prescribing incorrect frequency accounting for 37.5% of the total, followed by prescribing wrong medications accounting for 31.5% ([Table 3](#pone.0233486.t003){ref-type="table"}). Losartan (35%; 22/63) and omeprazole (21%; 13/63) were the medications most associated with incorrect frequencies as they were prescribed two times a day, deviating from the recommended guidelines.

10.1371/journal.pone.0233486.t003

###### Types of prescribing errors.
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  Type of prescribing errors                                                                                                                                                                                                                    Frequency (%) \[N = 168\] [\*](#t003fn001){ref-type="table-fn"}   Examples
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Wrong frequency                                                                                                                                                                                                                               63 (37.5)                                                         • Nifedipine 20 mg immediate-release tablet was prescribed once a day for hypertension instead of three times a day.
  • Betahistine 16 mg was prescribed once a day for vertigo instead of three divided doses.                                                                                                                                                                                                                       
  • Long-acting glibenclamide 5 mg three times a day was prescribed instead of once a day.                                                                                                                                                                                                                        
  Wrong medication                                                                                                                                                                                                                              53 (31.5)                                                         • Glibenclamide 5 mg three times a day was prescribed which could induce hypoglycemia in older adults due to its long action.
      *I*. *Potential adverse drug reactions*                                                                                                                                                                                                   *7 (4.2)*                                                         • Prazosin 2 mg three times a day was prescribed as an antihypertensive which increases the risk of hypotension in older adults.
      *II*. *Unnecessary medications*                                                                                                                                                                                                           *29 (17.3)*                                                       • Vitamins, calcium supplements, proton pump inhibitors, antihistamines, and non-steroidal anti-inflammatory medicines prescribed without evidence of a justifiable indication.
      *30 Drug interactions*                                                                                                                                                                                                                    *9 (5.3)*                                                         • Metoprolol and amlodipine prescribed together which could cause a significant drug interaction by increasing anti-hypertensive effect. Advised to monitor closely.
  • Olanzapine and benzhexol prescribed together which could cause a significant drug interaction by increasing anti-cholinergic side effects. Advised to monitor closely.                                                                                                                                        
  • Fluoxetine and haloperidol prescribed together which could cause a serious drug interaction. Fluoxetine inhibits the metabolism of haloperidol by inhibiting metabolism by hepatic enzyme CYP2D6. Advised to use an alternate medication.                                                                     
      *10 Duplications or inappropriate medication combinations*                                                                                                                                                                                *8 (4.7)*                                                         • Prescribed both losartan and enalapril together which is a dual blockade of the renin-angiotensin system.
  • Prescribed both omeprazole and famotidine together which are acid-suppressing agents when either one is adequate.                                                                                                                                                                                             
  • Prescribed two types of vitamin B supplements to the same resident.                                                                                                                                                                                                                                           
  • Prescribed both salbutamol oral tablets and metered-dose inhaler when inhaler alone is adequate and safer in asthma management.                                                                                                                                                                               
  Omission of medications                                                                                                                                                                                                                       25 (14.9)                                                         • Not prescribing of a proton pump inhibitor for a resident who was on both aspirin 75 mg and clopidogrel 75 mg.
  Wrong dose                                                                                                                                                                                                                                    16 (9.5)                                                          • Omeprazole 40 mg twice a day prescribed to prevent non-steroidal anti-inflammatory drug (NSAIDs) associated gastric ulcers, but 20 mg daily is the preferred dose.
  • Spironolactone 20 mg mane was prescribed instead of 25 mg.                                                                                                                                                                                                                                                    
  Untreated indications                                                                                                                                                                                                                         9 (5.4)                                                           • Resident's past clinic records indicate hypertension (repeatedly high blood pressure values) but no antihypertensive prescribed (excluded intentional omission).
  Wrong dosage form                                                                                                                                                                                                                             2 (1.2)                                                           • Residents with a past history of non-adherence to medications was prescribed diltiazem 30 mg three times a day which could be converted to once a day sustained-release form to improve adherence.
  • Salbutamol tablets prescribed instead of a salbutamol inhaler for a resident with chronic bronchial asthma                                                                                                                                                                                                    

\*Used as the denominator for calculating percentages

Wrong medications were further classified into four sub-categories (unnecessary medications, duplication of medications and inappropriate medication combinations, drug interactions, and potential adverse drug reactions (ADRs)). [Table 3](#pone.0233486.t003){ref-type="table"} shows the prevalence of sub-categories of wrong medications.

In total, nine drug interactions were identified ([Table 3](#pone.0233486.t003){ref-type="table"}), of which two were considered serious. These interactions should have been addressed by using alternative medications. Seven potential adverse drug reactions were identified which required close monitoring of the residents. None of these residents appeared harmed at the time of the study and hence belonging to NCC MERP Category C (an error occurred that reached the patient but did not cause patient harm) or Category D (an error occurred that reached the patient and required monitoring to confirm that it resulted in no harm to the patient and/or required intervention to preclude harm). Residents were not monitored beyond the point of data collection; hence we could not conclude if these prescribing errors resulted in hospitalization or mortality at a future date.

Dispensing errors {#sec015}
-----------------

Mean dispensing errors per resident was 15.9±13.1 \[median, 14.0 (6.00--22.75)\], and accounted for 3.6 dispensing errors for every medication dispensed. Ninety-five percent of residents had medications with at least one dispensing error. Only 2.4% (11/446) of medications had complete dispensing labels.

Absence of information on the duration of treatment in the dispensing label was the commonest dispensing error (19.5%), followed by lack of provision of medication specific special instructions (18.6%) ([Table 4](#pone.0233486.t004){ref-type="table"}). More than 75% of the dispensing labels contained only dose and frequency.

10.1371/journal.pone.0233486.t004

###### Types of dispensing errors.
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  Types of dispensing errors                                                              Frequency, (%) \[N = 1594\][\*](#t004fn001){ref-type="table-fn"}   Examples
  --------------------------------------------------------------------------------------- ------------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------
  Wrong or missing duration of treatment on a dispensing label                            311 (19.5)                                                         Domperidone duration was missing in the dispensing label.
  Wrong or missing special directions for use                                             296 (18.6)                                                         Twice a day dose of furosemide was written as morning and night in the dispensing label instead of morning and 2.00 p.m.
  Wrong or missing name of medication on a dispensing label                               280 (17.6)                                                         The medication name was missing on the dispensing label when dispensing carbamazepine.
  Wrong or missing dosage form of medication on a dispensing label                        235 (14.7)                                                         Nifedipine 20 mg sustained release form was indicated on the dispensing label of a medication pack containing nifedipine 20 mg immediate-release form.
  Wrong or missing dose of medication on a dispensing label                               231 (14.5)                                                         Dose of losartan potassium was missing on the dispensing label.
  Wrong or missing the total number of medication units dispensed on a dispensing label   135 (8.5)                                                          Total number of folic acid tablet units dispensed was missing on the dispensing label.
  Wrong or missing frequency of medication on a dispensing label                          106 (6.6)                                                          Frequency of metformin administration was missing on the dispensing label.

\*Used as the denominator for calculating percentages

Medication administration and storage errors {#sec016}
--------------------------------------------

Mean medication administration errors per resident were 0.95±1.5 \[median, 0.00 (0.00--1.00)\]. Ninety-five medication administration errors were identified and there were 45 residents with at least one administration error. Twenty-seven of these residents were assisted by caregivers and 18 administered medications themselves. One half (50.5%) of the medication administration errors were due to medication omissions, followed by wrong dose (23.2%), wrong timing (15.8%), extra doses (7.3%), and wrong frequency (3.2%) ([Table 5](#pone.0233486.t005){ref-type="table"}). Wrong drug, wrong dosage form, and wrong route of administration errors were not observed.

10.1371/journal.pone.0233486.t005

###### Medication administration errors among residents.
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  Types of medication administration errors   Frequency (%) \[N = 95\] [\*](#t005fn001){ref-type="table-fn"}   Examples
  ------------------------------------------- ---------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------
  Medication omission                         48 (50.5)                                                        Benzhexol 2 mg twice a day was prescribed, however, the resident did not administer the medication.
  Wrong dose                                  22 (23.2)                                                        Gliclazide 40 mg was administered instead of 80 mg.
  Wrong time                                  15 (15.8)                                                        Atorvastatin 20 mg was administered in the morning instead of night as prescribed.
  Taken extra doses of medication             7 (7.3)                                                          Folic acid 1 mg was prescribed once a day, but five residents administered it twice a day.
  Wrong frequency                             3 (3.2)                                                          Carbidopa+levodopa 275 mg was prescribed four times a day, but the resident administered only morning and night dose.

\*Used as the denominator for calculating percentages

Among the medications evaluated, there were 143 storage errors, of which 83 (58%) medications were not properly separated from other medications when storing; 50 medications were stored in containers contrary to recommendations (ex: Storing in plastic bags, sheet of paper to wrap the tablets), and 10 were exposed to inappropriate temperatures and excess sunlight ([Table 6](#pone.0233486.t006){ref-type="table"}).

10.1371/journal.pone.0233486.t006

###### Types of storage errors.
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  Types of storage errors                                 Frequency (%)   Examples
  ------------------------------------------------------- --------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------
  Inadequately separated from other medications           83 (58)         A resident stored all of her antihypertensives, anti-rheumatic drugs and oral hypoglycemics (eight different types of medications) in the same container
  Use of inappropriate containers                         50 (35)         Glyceryl trinitrate tablets were stored in transparent bottles or plastic bags
  Suboptimal storage temperature or exposed to sunlight   10 (7)          Opened insulin vials were stored at room temperature (30°C)

\*Used as the denominator for calculating percentages

Discussion {#sec017}
==========

The logistical steps in the medication use process in general comprise prescribing, dispensing, medication administration and monitoring of medication use \[[@pone.0233486.ref033]\]. The latter processes should entail the care and oversight of several healthcare professionals in order to ensure safe delivery of medications. It is evident from our study that residents evaluated in nine elderly care homes in Sri Lanka were potentially susceptible to medication errors by virtue of various lapses and lack of oversight. Alarmingly, almost all (99%) of the elderly care home residents who participated in our study were exposed to one or more medication errors. Although not comparable with our study, Hanlon et al., \[[@pone.0233486.ref034]\] too showed that more than 90% of elderly inpatients in United States received one or more inappropriate medicines with high-severity outcomes \[[@pone.0233486.ref034]\].

There was a relatively high prevalence of one or more prescribing errors amongst some three quarters (85%) of the evaluated cohort. However, it is difficult to compare this result with most other data where disparate instruments have been used to assess inappropriate medication use, for instance Barber N et al. \[[@pone.0233486.ref005]\], Rousseau A et al. \[[@pone.0233486.ref019]\], Storms H et al. \[[@pone.0233486.ref035]\] used Beers' criteria, Screening Tool of Older People\'s Prescriptions (STOPP), Screening Tool to Alert to Right Treatment (START) criteria, and Medication Appropriateness Index (MAI). Although there are no published data on elderly care homes, two previous hospital studies conducted in Sri Lanka have identified that nearly 70% of non-communicable chronic disease patients had inappropriate medications in their discharge prescriptions \[[@pone.0233486.ref036], [@pone.0233486.ref037]\]. The types of prescribing errors frequently observed in our study is also consistent with another study conducted among in-patients in a tertiary care hospital in Sri Lanka \[[@pone.0233486.ref022]\]. According to two recent systematic reviews published by Storms et al. 2017 \[[@pone.0233486.ref035]\] and Ferrah et al. 2016 \[[@pone.0233486.ref014]\], the prevalence of inappropriate medication use varies from 16%--82.6% among residents in elderly care homes. It is tempting to speculate that the disparate results in these studies are likely to be due to the different study instruments used.

Two serious drug interactions were identified in our cohort, where alternative medications were recommended. In addition, seven potential adverse drug reactions were also identified that may have necessitated close monitoring of the affected residents. Though the aim of our study was not to monitor the long term adverse effects of poor medication dispensation, some of the errors we noted particularly potential adverse drug reactions or serious drug interactions, may have reduced the quality of life of the residents. These adverse findings further justify the necessity to monitor and mandate residents' medication use by trained healthcare professionals.

The mean number of dispensing errors per resident we noted, was considerably higher (15.9 vs. 0.73) compared to a study done by Barber N et al. \[[@pone.0233486.ref005]\] in UK. This may be because we counted incomplete dispensing label errors, which is a common problem in Sri Lanka \[[@pone.0233486.ref023], [@pone.0233486.ref038]\] and other developing countries \[[@pone.0233486.ref039]--[@pone.0233486.ref041]\]. Interestingly, previous studies conducted in different settings in Sri Lanka, including hospitals, community pharmacies and household surveys have reported that more than 50% of medicines had incomplete dispensing labels \[[@pone.0233486.ref023], [@pone.0233486.ref038]\]. This is a rather serious predicament particularly in elderly care homes where untrained caregivers are sometimes administering medicines.

One half of residents experienced one or more medication administration errors during the relatively short study period of three months. This is similar to many other studies which report a high incidence of administration errors in elderly care homes \[[@pone.0233486.ref005], [@pone.0233486.ref013]\]. Failing to administer/omitting medications and administering a wrong dose were the most common types of medication errors we observed, a finding similar to care homes in UK \[[@pone.0233486.ref005]\]. The similarity of these findings between low and high-income countries indicate the universal nature of medication safety issues among this vulnerable group, and the urgent need to address this widespread issue.

The most common storage error found among residents was keeping all medication packets in one container such as a plastic box or a paper bag, and not in their original packaging. Inappropriate storage practices can directly affect the potency of medications. This is especially important for medication with a narrow therapeutic index and could result in loss or reduction in medication efficacy, as well as medication administration errors \[[@pone.0233486.ref042]\]. However, it should be noted that the majority of Sri Lankans do not use pill organizers or pillboxes to store and organize their medications and they tend to keep their medication in the original envelopes or plastic bags used to dispense the medication. Incidentally, we also observed that some residents did not store opened insulin vials in the refrigerator. Insulin is a protein-containing product which could induce its degradation at high temperature leading to loss of the desired therapeutic effect \[[@pone.0233486.ref043]\].

Although there have been numerous household surveys conducted worldwide to monitor storage practices of medications at home \[[@pone.0233486.ref024], [@pone.0233486.ref031], [@pone.0233486.ref044]\], none have evaluated the storage practices at care homes. Hence, this study, for the first time, demonstrate the necessity and the importance of educating this vulnerable population on appropriate storage practices to safeguard safety, quality and efficacy of the medications they use.

Lack of qualified and trained healthcare staff, busy medication administration rounds and inadequate regular medication reviewing could be the most likely reasons for the high incidence of medication errors among residents in long-term aged care facilities \[[@pone.0233486.ref005]\]. However, to our knowledge, there is no study that has been conducted in South Asian countries to observe this phenomenon. Our study although limited in sample size provides insights into the medication safety issues related to all three main logistical steps (prescribing, dispensing and medication administration) that entail the medication use process, and hence can be used in a beneficial, proactive way to mitigate these risks among this population.

Strengths and limitations of our study needs to be acknowledged. Although limited to a single district, our study was a multi-center study. However, this district is the commercial capital and the most populated district in Sri Lanka and hence may be generalizable to some extent. Multiple study instruments (prescription and dispensing label review, interview and direct observation) were used to collect data to ensure reliability. In addition, to interviewing and reviewing of medical records, we directly observed administration practices of residents and/or caregivers. Although there is a concern that such observations may affect the prevalence of administration errors, a UK study on observing nurses during medication administration rounds showed that direct observation did not significantly affect the medication administration errors \[[@pone.0233486.ref005]\]. One major limitation of this study is the limited number of participants we were compelled to recruit and the resultant convenient sample of ours. Although 366 residents were initially approached, most had to be excluded due to the perceived barriers on obtaining reliable information. Therefore, residents with poor cognition, or communication issues, and those without the support of a competent caregiver could not be included. As we failed to document reasons for exclusion, and the demographic characteristics of the excluded residents, post-analysis of excluded residents was also not feasible. Hence, our results should be interpreted with caution due to the foregoing selection bias. Furthermore, as this was a cross-sectional study, we did not monitor patient harm beyond the point of data collection, for instance it was not possible to monitor patient's blood pressure and glucose concentration as these were missing on some of the medical notes. Therefore, the classification of harm caused by prescribing errors could not be classified beyond Category C (an error occurred that reached the patient but did not cause patient harm) and D (an error occurred that reached the patient and required monitoring to confirm that it resulted in no harm to the patient and/or required intervention to preclude harm) of the NCC-MERP classification. Although most residents received support from the caregiver for administering medicines, we did not perform a sub-analysis based on their education level and assistance received by the caregiver, again due to the small sample size. However, we believe that these limitations did not affect the main message of this study, that prescribing, dispensing, medication administration and storage errors are rather rampant among residents of elderly care homes in Sri Lanka irrespective of the education level or supportive care. Other studies have shown that under such circumstances, interventions by competent healthcare personnel can improve medication safety among residents in care homes \[[@pone.0233486.ref025], [@pone.0233486.ref045], [@pone.0233486.ref046]\]. Jordan et al in 2015 \[[@pone.0233486.ref046]\] for instance, conducted a stepped wedge cluster randomized trial to assess the effectiveness of a nurse-led medicines\' monitoring intervention for patients with dementia in care homes and reported an improvement in safety of care. Similar interventional studies could be initiated in Sri Lanka to assess effective ways to utilize services of healthcare professionals such as pharmacists, to improve medication safety among residents in elderly care homes.

Conclusions {#sec018}
===========

The findings of this study indicate that prescribing, dispensing, medication administration and storage errors are prevalent among residents in elderly care homes in Sri Lanka. Wrong administration frequencies in prescriptions, as well as missing information on duration of treatment on dispensing labels, and failing to administer medication, were commonly observed. All medication errors observed were preventable with suitable system changes. As it is immoral and unethical to neglect older adults who reside in elderly care homes we contend these must be considered a priority in healthcare delivery systems. The services of trained resident healthcare professionals are vital to ensure medication safety among this older population. Finally, it is essential that a regular review of the residents' prescriptions is completed by either a doctor or a pharmacist in order to minimize prescribing errors.
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Your statement in the first paragraph is not supported by the references

A review of the literature is too flawed!
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Methods

Add the research time to the methods

Number of samples based on what study was calculated?

You have sampled about a quarter of the calculated sample size, which reduces the credibility of the study!

Your study plan (assessment of prescribing, dispensing, medicines administration and storage errors) should be supported by the previous same research.

The sentence: \"The Australian Pharmaceutical Formulary (AFP) was used as a reference to assess the appropriateness of dispensing practices\" need a suitable reference.
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Because drug errors also are related to caregivers, their information should be taken into account for more comprehensive examination.
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Discussion

You did not provide any information about the health care workers in results, therefore, you should not focus on this issue in the discussion (first paragraph).
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Style
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Sample size is not based on any stated outcome.
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An old version of spss was used. Proportions can be compared in spss, but I did not see any such comparisons in the results.

Many common long-term conditions do not appear to be included e.g. mental health problems, respiratory conditions, and epilepsy. This limits the generalisation of findings.
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Discussion

The observational nature of this work is an important limitation. Were the observed vulnerable to any biases? Patient selection further limits generatlisation.

Conclusion

In my view, this study confirms the pervasiveness of the problems, and intervention studies are now needed (Jordan et al 2015).

Jordan et al 2015 Nurse-Led Medicines\' Monitoring for Patients with Dementia in Care Homes: A Pragmatic Cohort Stepped Wedge Cluster Randomised Trial
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Comment 3: We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.

Response 3: Thank you and we have now subjected the manuscript for language edition.
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Reviewer comments

Reviewer 1:

Comment 1: The text requires editing by an English native person

Response 1: Thank for the request and the paper was subjected to the edition by a native English speaker.

Name: Ms Cathy Lynch - a clinical pharmacist and a member of Collaborative of Australian Sri Lankan Pharmacy Practice Education Research (CASPPER)

Introduction

Comment 2: The introduction is very weak and should be improved. The first paragraph is very extensive and should be summarized. Your statement in the first paragraph is not supported by the references. A review of the literature is too flawed! Should justify why this research do.

Response 2: Thank you for the comment. We have now revisited the introduction and improved it. We have also rearranged the introduction section highlighting the importance of conducting this research in Sri Lanka. References have been added where necessary.

Methods

Comment 3: Add the research time to the methods

Response 3: The period was added and shown in line number 163

Comment 4: Number of samples based on what study was calculated?

Response 4: The question is not clear. However, if the query is if we based the sample size calculation on a previous study, then the response is that we used an online sample size calculator and calculated the sample size using stated parameters. This method, however, has been used by others and we added this in the manuscript with appropriate referencing.

(Line number 109-112)

Comment 5: You have sampled about a quarter of the calculated sample size, which reduces the credibility of the study!

Response 5: Thank you for the comment and this reduced sample size is one of the limitations in our study. We have acknowledged it in the limitation section (Line number 120 and 336). The study was mainly conducted in the Colombo district (the Commercial capital of Sri Lanka) as it has the highest population density in Sri Lanka. As explained in the methodology, though the records of the Social Services Department shows the existence of 34 elderly care homes, only 14 actually existed and 09 were accessible. We approached each participant in all 9 care homes, but a considerable number did not fulfil the inclusion criteria. Unfortunately, we have not documented the demographics of those excluded nor the specific reason for exclusion, hence difficult to present a systematic flowchart of participant recruitment. This too has now been acknowledged in the limitations. However, we have tried to the best of our ability to showcase the details of participant recruitment and Table 1 which shows how many participants resided in each care home and the % selected for the study has been added.

Comment 6: Your study plan (assessment of prescribing, dispensing, medicines administration and storage errors) should be supported by the previous same research.

Thank you and we agree. Our group has been engaged in research on medication safety in the past and the assessment methodologies of prescribing and dispensing errors are based on our previous experiences which have already been published. Our previous studies and other relevant studies have been added as references (Line number 129-132, 136-138, 143-144). Assessment of drug administration errors (Line number 152-154) and medicine storage errors (Line number 159) are very commonly assessed using direct observation. We have added references to support this methodology.

Comment 7: The sentence: \"The Australian Pharmaceutical Formulary (AFP) was used as a reference to assess the appropriateness of dispensing practices\" need a suitable reference.

Response 7: The Australian Pharmaceutical Formulary (AFP) is an accepted reference used to guide pharmacists in good dispensing practices. We have now added the edition number and name of the full reference in the reference list (Line number 147-148). This book has instructions for dispensing labels and the relevant medication administration instructions for patients. This is the National formulary used by pharmacists in Australia.

Comment 8: Exactly explain the checklist and questionnaire and its validity and reliability should be mentioned (if done)

Response 8: Thank you for the comment. All the checklists and questionnaires used have been added as supplementary material. In addition, the questionnaire and checklists were content validated by two other academics pharmacists and were piloted for feasibility among ten elderly persons who were not part of the study. This too has been added to the methodology now (Line number 165-167).

Comment 9: In the data analysis section, p \<0.05 was considered as a significant level, but in the findings, you did not report p (Although, in my opinion, you only used descriptive statistics).

Response 9: Thank you for your concern. Yes as we considered only descriptive statistics which we believe is adequate to be inline with our objectives. We did not perform any comparisons and we did not use "P" values. Now we have removed this redundant sentence from the analysis section.

Comment 10: Line 155: change to SPSS version 16

Response 10: Changed to "Version 16" (Line number 174).

Comment 11: Because drug errors also are related to caregivers, their information should be taken into account for more comprehensive examination.

Response 11: We agree with your comment and this information would have greatly improved our paper. However, the association or relationship between knowledge, education level or other contributory factors of residents or caregivers and the occurrence of medication errors was not an objective of this paper. Besides, a sub-analysis was discouraged due to the already small sample size. We have acknowledged this as a limitation in the manuscript (Line number 124).

Comment 12: The inferential statistics should also be used to analyze the data.

Response 12: Thank you for your comment. The main objectives of this study were to assess and report the existence and prevalence of medication errors (prescribing, dispensing, administration and storage errors) among this vulnerable population in the South Asian part of the world where such data is scarce. Hence inferential statistics were not used. We could have compared data of each elderly home but did not do so as a sub-analysis would not be of value due to the small sample size. We hope this is acceptable to the reviewers and would be grateful for further guidance.

Results

Comment 13: Table 1: Abbreviations should be explained

Response 13: Thank you and we have added a list of abbreviations now.

Comment 14: Tables can be better designed

Response 14: Now we have expanded the tables by including examples for each error category (Table 3,4,5, and 6)

Comment 15: Other chronic diseases can be added if the information is available

Response 15: Thank you and the major diseases have been included now. The minority has been added as 'Others' with the breakdown in a footnote. Further, on scrutiny, we have detected an error where we have added frequencies instead of percentages. We have corrected this mistake (Table 2).

Discussion

Comment 16: You did not provide any information about the health care workers in results, therefore, you should not focus on this issue in the discussion (first paragraph).

Thank you and we agree. We have now removed this section from the discussion.

Comment 17: Some of the content in the first paragraphs of the discussion is suitable for introduction

In the discussion section, the results should be explained and not repeated (especially in the third paragraph)

In discussion use fewer numbers

Again, you just repeat the results in discussion.

Response 17: Thank you for this constructive comment and now we have rewritten the discussion. Repetition of the results in the discussion has been removed and discussed further with examples from the literature.

Comment 18: The literature review should be more comprehensive and the discussion should be better written

Response 18: Thank you for the comment and now we have rewritten the discussion considering all your valuable comments.

Reviewer 2:

Comment 1: Style

Extensive copy editing will be needed. The manuscript should be revised by a native English speaker.

Response1: Thank for the request and the paper was edited by a native English speaker.

Abstract

Comment 2: Numbers should be given, alongside %s.

Response 2: Percentages were added (Line numbers 42,43,46 and 48).

Literature

Comment 3: The reference lists needs to be updated: the more recent citation was 2015, and most citations were pre-2010. There are a plethora of studies and reports in this field, and a more detailed examination of the literature in needed to justify inclusion in Plos One.

Response 3: Thank you for the comment and now we have arranged the introduction giving the most recent literature.

Methods

Comment 4: I did not see the dates of data collection.

Response 4: Dates of data collection were added (Line number 163).

Comment 5: The types of errors observed should all be defined, with references.

Response 5: The types of errors observed were based on a list of definitions prepared in-house but based on published literature. The list of definitions have now been added as supporting material (S1 Table) and due references have been added.

Comment 6: The authors should justify the exclusion of residents with poor cognition and communication. How many potential participants were excluded for these reasons? This introduces a selection bias.

Response 6: We have now re-worded the exclusion criteria as 'Residents with poor cognition and communication issues without the assistance of competent caregiver' as this was the practice we adhered to. 6.9% of the patients included in the study had mental illnesses as they had competent caregivers. Those without caregiver assistance were excluded as they may not be able to provide reliable answers to a medication history interview and may not be able to comprehend the questions asked by researchers. The assistance of caregivers who were informed or competent enough to provide information was not uniformly available at all homes. Hence, we were compelled to exclude them from the study. Due justification has been added to the manuscript now (Line number 338-340).

Comment 7: Sample size is not based on any stated outcome.

Response 7: The sample size was not based on any primary outcomes as we were unable to find out the baseline statistical figures from the South Asian region which has a similar setup to Sri Lanka. Therefore, it was decided to calculate the sample size based on the prevalence of population aged 60 years and above in Sri Lanka (12.4%, 2016) with a 95% confidence level and 5% of margin of error. This explanation is now added to the manuscript. This method too is supported by a published study by Hasan et al, who has evaluated the medication appropriateness and frailty among residents of aged care homes in Malaysia which is a Southeast Asian country. This reference has been added (Line number 109-112).

Comment 8. The instruments used should be referenced or appended.

Response 8: Thank you for the comment. We used a prescription and medicine label review for detecting prescribing (Line number 136-138) and dispensing errors (Line number 143-144) and direct observation for detecting drug administration (Line number 152-154) and storage errors (Line number 159). The data collection forms and checklists used for gathering this information are now submitted as supporting material (S1 -- S4 files).

Comment 9:. An old version of spss was used. Proportions can be compared in spss, but I did not see any such comparisons in the results.

Response 9: We agree. There was no comparison of proportions. Hence the said sentence has been removed.

Comment 10: Many common long-term conditions do not appear to be included e.g. mental health problems, respiratory conditions, and epilepsy. This limits the generalisation of findings.

Response 10: The list of all the long-term conditions is now incorporated under Table 2. Our sample has 6.9% of residents with mental health and 4.6% of residents with respiratory diseases (Table 2).

Results

Comment 11: A flow chart is needed for residents, in addition to that for homes.

Response 11: Thank you and as previously mentioned in a comment by reviewer 1, we have included a table (Table 1) in the methodology section showing how many residents were living in the care homes and the percentage of residents selected for the study. Those excluded did not fulfil the inclusion criteria. Unfortunately, we have not documented the details of exclusion, hence difficult to present a systematic flowchart of participant recruitment. This too has now been acknowledged in the limitations (Line number 340-342).

Comment 12: Please explain abbreviations and categories.

Response 12: Abbreviations and categories have been explained.

Comment 13: This is a descriptive, rather than a quantitative study. This is fine, but the descriptions need to enriched.

Response 13: We have used quantitative and qualitative methodologies but the outcomes are presentable numerically. We have included examples where ever possible and tried to enrich the descriptions to the best of our ability. Please guide us further if more is needed.

Comment 14: The tables all need to be augmented with detailed examples and case reports. To understand the data, readers need to know what was administered and what should have been administered, and how often, with references.

Response 14: Thank you and we agree. As previously mentioned in a comment by reviewer 1, we have re-visited the examples given for each medication error and included where possible what should have been given and how often. The references used were BNF and AMH and they have been referenced accordingly.

Comment 15: Did the potential ADRs cause harm? What happened to the residents? What were the effects of the interactions?

Response 15: None of the residents receiving these inappropriate medicines were harmed at the time of the study and hence belonged to Category C (an error occurred that reached the patient but did not cause patient harm) or Category D (an error occurred that reached the patient and required monitoring to confirm that it resulted in no harm to the patient and/or required intervention to preclude harm) of the NCC MERP Index for Categorizing Medication Errors. Residents were not monitored beyond the point of data collection, hence could not conclude if these prescribing errors resulted in hospitalization or death in a future date. This has been added in the results section now. We have also mentioned this as a limitation of the study now (Line number 342-343).

Comment 16: What would have been 'justifiable indications' for vitamins etc? (Some authors recommend universal vitamin D.)

Response 16: Thank you for the comment. In this study protocol, we were compelled to use a limited number of references to ensure straightforward decision making. In Sri Lanka, the most common reference used by prescribers is the BNF. Hence BNF was used as the primary reference source when detecting prescribing errors. A second reference was also added to confirm the prescribing error. The researchers reviewed the prescription and matched the diagnosis/medical history with medicines prescribed. If the prescribed medicine was not indicated for the disease in at least one of the references used, it was taken as an error. The same method was used for vitamins etc. References used have been added to the reference list now. However, at present the necessity of routine vitamin D supplementation has not been established in our country nor added in the formularies hence was not considered as a requirement for patients.

Comment 17: What alternatives were substituted? Were some duplicate medicines added for good reasons? All these prohibitions need references.

Response 17: Duplicate medicines were defined as medicines from the same pharmacological group with the same mechanism of action. Hence duplicate medicines cannot/should not be added for a good reason. Some medicine combinations were not from the same group but have no clinical benefit when used together. These combinations were termed as 'Inappropriate medicine combinations'. The definition list has now been appended (S1 Table).

Comment 18: Which medicines were inappropriately stored? SmPCs should be referenced here.

Response 18: We have now added the examples for all of these error types and their categories in Table 6. The references used to guide us on detecting storage errors has also been added in the reference list.

Discussion

Comment 19: The observational nature of this work is an important limitation. Were the observed vulnerable to any biases? Patient selection further limits generatlisation.

Response 19: Though there is a concern that observation may affect the prevalence of administration error, it is evident from the literature that direct observation had no significant effect on medicine administration errors. This has been added into the discussion now with an appropriate reference (Line number 333-335).

Conclusion

Comment 20: In my view, this study confirms the pervasiveness of the problems, and intervention studies are now needed (Jordan et al 2015).

Jordan et al 2015 Nurse-Led Medicines\' Monitoring for Patients with Dementia in Care Homes: A Pragmatic Cohort Stepped Wedge Cluster Randomised Trial

<http://dx.plos.org/10.1371/journal.pone.0140203>

Response 20: Thank you and we agree. We have added this phrase to the discussion with this reference (Line number 354-358).
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Reviewers\' comments

Reviewer \#1: The authors have addressed most of my concerns regarding the original version of the paper and made substantial improvements. However, there are still some minor revisions that I believe are necessary prior to publication. Specifically:

General

The entire manuscript should be reviewed in term of language punctuation

Introduction

"Labour" change to " labor"

"Ageing" change to "aging"

Line 57: are change to "is"

Line 69: 'carers" should be replaced with a better word

Line 71: United State (US)

Line 90: "may be" change to "maybe"

Line 90: "to" change to "from"

Methods

Line 115: However,

Result

Line 198: Eighty-five percent of residents

1ine 203: most

Discussion

Line 293: "carers" should be replaced with a better word

Line 311: "household"

Reviewer \#2: Thank you for the opportunity to re-review this observational study.

Thank you for adding examples of care -- this makes it much easier to understand the problems.

Abstract

Line 43, administration error numbers were not normally distributed, so the median and 25th-75th centiles should be quoted. Please could the statistician also check that other parameters were normally distributed before quoting just the means and SDs.

Introduction

Line 67. Please could you confirm that the social care workers were all unpaid? This would not be the case in the UK, so an explanation would be helpful.

Lines 80-83. It seems that there are conclusions in the introduction.

Sample size

This is a convenience sample. The calculation presented bears no relation to the outcomes investigated. I suggest remove the calculation and explain the factors limiting the study size.

Sample selection

Line 14. Did the homes refuse access or consent?

How many residents were excluded because they were \<60? How many actually refused?

Process

Line 137. Were these references the current editions at the time of the study? if so, need to state this.

Errors

Line 203. Need to say in what way the frequencies were incorrect.

Discussion

Lines 343 et seq. to state that no harm occurred, the BPs and glucose concentrations need to be given. What checks were undertaken to ensure there were no signs and symptoms that might have attributable to the errors? If none, this might be a limitation of the study.

References

Some updating is needed e.g. annual health bulletin 2016 \[2\].

Style

There are a few problems with English, which will need the attention of copy editors.

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Author response to Decision Letter 1

20 Feb 2020

Reviewer 1: The authors have addressed most of my concerns regarding the original version of the paper and made substantial improvements. However, there are still some minor revisions that I believe are necessary prior to publication. Specifically:

Comment 1

General

The entire manuscript should be reviewed in term of language punctuation

Response 1

The manuscript was edited by a native English speaker previously and now being thoroughly reviewed by the authors.

Comment 2

Introduction

"Labour" change to " labor"

Corrected (Please refer Line 62)

"Ageing" change to "aging"

Corrected (Please refer Line 55)

Line 57: are change to "is"

Corrected (Please refer Line 56)

Comment 3

Line 69: 'carers" should be replaced with a better word

Response 3

Replaced with caregivers (Please refer Line 70)

Comment 4

Line 71: United State (US)

Response 4

Changed (Please refer Line 72)

Comment 5

Line 90: "may be" change to "maybe"

Response 5

Changed (Please refer Line 88)

Comment 6

Line 90: "to" change to "from"

Response 6

Changed (Please refer Line 89)

Comment 7

Methods

Line 115: However,

Response 7

Edited (Please refer Line 111)

Comment 8

Result

Line 198: Eighty-five percent of residents

Response 8

Edited (Please refer Line 191)

Comment 9

Line 203: most

Response 9

Changed (Please refer Line 196)

Comment 10

Discussion

Line 293: "carers" should be replaced with a better word

Response 10

Replaced with the word "caregivers" (Please refer Line 288)

Comment 11

Line 311: "household"

Response 11

Edited (Please refer Line 305)

Reviewer 2:

Abstract

Comment 1: Line 43, administration error numbers were not normally distributed, so the median and 25th-75th centiles should be quoted. Please could the statistician also check that other parameters were normally distributed before quoting just the means and SDs.

Response 1

Now we have shown both the mean (standard deviation) and median (25th-75th centiles) values in the abstract and the main text.

Introduction

Comment 2: Line 67. Please could you confirm that the social care workers were all unpaid? This would not be the case in the UK, so an explanation would be helpful.

Response 2

Some of the social care workers at residential care homes work voluntarily and are not paid a formal salary while some are hired as paid staff. The sentence was re-worded as follows.

"Most of these facilities do not employ trained healthcare professionals but employ staff who have not received any formal training on safe use of medicines."

Comment 3: Lines 80-83. It seems that there are conclusions in the introduction.

Response 3

Thank you and we agree. Now we have removed this part from the introduction.

Sample size

Comment 4: This is a convenience sample. The calculation presented bears no relation to the outcomes investigated. I suggest remove the calculation and explain the factors limiting the study size.

Response 4

Thank you and we agree. Now we have removed the description of the sample size calculation.

Sample selection

Comment 5: Line 14. Did the homes refuse access or consent?

Response 5

The homes did not grant permission for researchers to approach the residents and thereby refused access. Now we have reworded it in the manuscript (Please refer Line 109).

Comment 6: How many residents were excluded because they were \<60? How many actually refused?

Process

Response 6

Unfortunately, we have not documented the demographics of those excluded nor the specific reason for exclusion. We only considered if participants matched the inclusion criteria. Hence, it is not possible to answer this query.

Comment 7: Line 137. Were these references the current editions at the time of the study? if so, need to state this.

Response 7

Yes, the study was conducted in 2016 and the team used the current latest available editions at that time. The following was added,

"The current and latest available editions of British National Formulary (BNF) (Version 71) \[26\], the Australian Medicines Handbook (AMH) \[27\] and Medscape Pharmacists \[28\] were used as references for detecting prescribing errors" (Please refer Line 130).

.

Errors

Comment 8: Line 203. Need to say in what way the frequencies were incorrect.

Response 8

Now we have discussed it (Please refer Line 196).

Discussion

Comment 9:

Lines 343 et seq. to state that no harm occurred, the BPs and glucose concentrations need to be given. What checks were undertaken to ensure there were no signs and symptoms that might have attributable to the errors? If none, this might be a limitation of the study.

Response 9

This observational study was carried out through reviewing documents and patient interview. As blood pressure values and glucose concentrations were not recorded on the patients' medication documents, it was not possible to identify medication related patient harm. This has now been acknowledged under limitation (Please refer Line 334).

References

Comment 10: Some updating is needed e.g. annual health bulletin 2016 \[2\].

Thank you however, in Sri Lanka, there is no health bulletin publication available after 2016.

Style

Comment 11: There are a few problems with English, which will need the attention of copy editors.

Response 11

The manuscript was edited by a native English speaker previously and now being thoroughly reviewed by the authors.
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Are medicines used safely among residents in elderly care homes? -- An observational multi-centred study in Sri Lanka

PLOS ONE

Dear Dr. Samaranayake,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Apr 20 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Prof, Mojtaba Vaismoradi, PhD, MScN, BScN

Academic Editor

PLOS ONE
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Reviewers\' comments:

Reviewer \#1: The quality of the paper considerably improved than the original version. I recommend this submission for acceptance with a minor revision: some lines and arrows are not straight in figure 1 that should be reformatted.

Reviewer \#2: Thank you for the opportunity to re-read this paper. Copy editing is needed.

I think it should be explained in the paper that some workers in care homes were unpaid, and worked voluntarily.

The sample size should be based on the primary outcome. This does not appear to be the case. It could be removed, as explained previously.

The next text indicates that 5 of 34 homes refused access, and 9 were recruited. Is there a typographical error? Line 109

Failure to note reason for exclusion is a major limitation, and should be discussed.

The case studies make this an interesting paper on an international topic that should be highlighted.

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Author response to Decision Letter 2

20 Apr 2020

Response to reviewer comments

Reviewer 1: The quality of the paper considerably improved than the original version. I recommend this submission for acceptance with a minor revision: some lines and arrows are not straight in figure 1 that should be reformatted.

Thank you for the comment and now we have done the required changes in the Figure 1.

Reviewer 2:

Thank you for the opportunity to re-read this paper.

Comment 1: Copy editing is needed.

Response 1: Thank you and in addition to English editing done by Ms Cathy Lynch, a Clinical Pharmacist and a member of Collaborative of Australian Sri Lankan Pharmacy Practice Education Research (CASPPER) in the previous submission the entire manuscript has been revisited by Professor Lakshman Samaranayake, Professor Emeritus, University of Hong Kong , Hong Kong and copy edited the article thoroughly. We hope this effort is satisfactory.

Comment 2: I think it should be explained in the paper that some workers in care homes were unpaid, and worked voluntarily.

Response 2: Please refer line 68-70. This comment was already addressed in the previous submission but we have now further emphasized that most workers are unpaid and work on a voluntary basis.

Comment 3: The sample size should be based on the primary outcome. This does not appear to be the case. It could be removed, as explained previously.

Response 3: In your previous comments, you had advised us to remove the sample size calculation and discuss the limitations. Taking this comment into consideration, we had already removed the sample size calculation from the methodology and explained the factors limiting the study sample size. However, taking this comment into consideration again, we have further elaborated that the sample selected for study is a convenience sample. We have also re-worded the relevant paragraph for better clarity (Line 107 -- 115).

Comment 4: The next text indicates that 5 of 34 homes refused access, and 9 were recruited. Is there a typographical error? Line 109

Response 4: It was not a typographical error. Of 34 elderly care homes registered, only 14 were functioning at the time of study. Out of the 14 functioning, 5 refused access and remaining 9 were approached. It is also mentioned in the manuscript text (Line 109 -- 115).

Comment 5: Failure to note reason for exclusion is a major limitation, and should be discussed.

Response 5: We have not recorded the individual reasons of the excluded sample, however, the overall elders who were excluded did not comply with at least one of our inclusion criteria. We have already acknowledged this in the limitation section (Line 342 -348). We have also acknowledged this limitation in the section dealing with sample size (Line 114-115) .

Comment 6: The case studies make this an interesting paper on an international topic that should be highlighted.

Response 6: Thank you for the comment and we believe no changes are required here.
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Dear Dr. Samaranayake,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at <https://www.editorialmanager.com/pone/>, click the \"Update My Information\" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

With kind regards,

Prof, Mojtaba Vaismoradi, PhD, MScN, BScN

Academic Editor

PLOS ONE

Reviewers\' comments:

Reviewer \#1: All comments have been addressed

Reviewer \#2: All comments have been addressed
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Are medications safely used by residents in elderly care homes? -- A multi-centre observational study from Sri Lanka

Dear Dr. Samaranayake:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

For any other questions or concerns, please email <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE.
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PLOS ONE Editorial Office Staff
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Professor Mojtaba Vaismoradi
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